Literature DB >> 3686577

Mycotic aneurysm, subarachnoid hemorrhage, and indications for cerebral angiography in infective endocarditis.

A V Salgado1, A J Furlan, T F Keys.   

Abstract

We compared the clinical course of 68 patients with infective endocarditis and mycotic aneurysm and 147 patients with infective endocarditis but no mycotic aneurysm. Among the patients with mycotic aneurysm, 57% had subarachnoid hemorrhage without warning. Forty-three percent had a neurologic prodrome 2 days to 18 months (median 17 days) prior to discovery of the mycotic aneurysm. A focal deficit consistent with embolism was the most common prodrome (23%). However, there was no significant difference in the frequency of neurologic symptoms between patients with and without mycotic aneurysm. During an average follow-up of 40 months, there were no instances of subarachnoid hemorrhage/mycotic aneurysm among 121 patients discharged after a full course of antibiotic therapy. Therefore, the risk of rupture of an unsuspected mycotic aneurysm following a full course of antibiotics is low. When a prodrome does precede a mycotic aneurysm, it most often is a focal deficit consistent with embolism. We favor angiography in all patients with infective endocarditis who experience a focal deficit with good recovery. The timing and other indications for angiography in infective endocarditis are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3686577     DOI: 10.1161/01.str.18.6.1057

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

1.  Brain magnetic resonance findings in infective endocarditis with neurological complications.

Authors:  Asako Azuma; Keiko Toyoda; Toshihiro O'uchi
Journal:  Jpn J Radiol       Date:  2009-05-03       Impact factor: 2.374

2.  Intracranial Aneurysms From Presumed Infective Endocarditis: The Dilemma of Persistently Negative Cultures.

Authors:  Jason Lockrow; Will Longstreth; Arielle P Davis
Journal:  Neurohospitalist       Date:  2015-09-21

3.  Mycotic aneurysm: an uncommon cause for intra-cranial hemorrhage.

Authors:  Sandip Bartakke; Ujjwala Kabde; Mamta N Muranjan; S B Bavdekar
Journal:  Indian J Pediatr       Date:  2002-10       Impact factor: 1.967

4.  Two cases of sudden death by rupture of traumatic and bacterial aneurysms.

Authors:  A Feldges; H E Nau; V Reinhardt
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 5.  Retrospective review of cerebral mycotic aneurysms in 26 patients: focus on treatment in strongly immunocompromised patients with a brief literature review.

Authors:  L M Allen; A M Fowler; C Walker; C P Derdeyn; B V Nguyen; A N Hasso; B V Ghodke; G J Zipfel; D T Cross; C J Moran
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-11       Impact factor: 3.825

Review 6.  Intracranial infectious aneurysms: a comprehensive review.

Authors:  Andrew F Ducruet; Zachary L Hickman; Brad E Zacharia; Reshma Narula; Bartosz T Grobelny; Justin Gorski; E Sander Connolly
Journal:  Neurosurg Rev       Date:  2009-10-16       Impact factor: 3.042

7.  Current treatment of active infective endocarditis with brain complications.

Authors:  Takashi Miura; Kiyoyuki Eishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-04-05

8.  Comparing magnetic resonance angiography (MRA) and computed tomography angiography (CTA) with conventional angiography in the detection of distal territory cerebral mycotic and oncotic aneurysms.

Authors:  Lara Walkoff; Waleed Brinjikji; Aymeric Rouchaud; Jildaz Caroff; David F Kallmes
Journal:  Interv Neuroradiol       Date:  2016-06-12       Impact factor: 1.610

9.  [Mycotic aneurysm in endocarditis lenta as the etiology of intraparenchymatous cerebral hemorrhage].

Authors:  M Würker; B Szelies; W Heindel; M Böhm; R Fischbach; W D Heiss
Journal:  Med Klin (Munich)       Date:  1998-05-15

Review 10.  [Neurological complications of infective endocarditis].

Authors:  K Angstwurm; A C Borges; E Halle; E Schielke; J R Weber
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.